Abstract
The beneficial effect of selenium (Se) on cancer is known to depend on the chemical form, the dose and the duration of the supplementation. The aim of this work was to explore long term antagonist (antioxidant versus toxic) effects of an inorganic (sodium selenite, Na2SeO3) and an organic (seleno-L-methionine, SeMet) forms in human immortalized keratinocytes HaCaT cells. HaCaT cells were supplemented with Na2SeO3 or SeMet at micromolar concentrations for 144 h, followed or not by UVA radiation. Se absorption, effects of UVA radiation, cell morphology, antioxidant profile, cell cycle processing, DNA fragmentation, cell death triggered and caspase-3 activity were determined. At non-toxic doses (10 μM SeMet and 1 μM Na2SeO3), SeMet was better absorbed than Na2SeO3. The protection of HaCaT from UVA-induced cell death was observed only with SeMet despite both forms increased glutathione peroxidase-1 (GPX1) activities and selenoprotein-1 (SEPW1) transcript expression. After UVA irradiation, malondialdehyde (MDA) and SH groups were not modulated whatever Se chemical form. At toxic doses (100 μM SeMet and 5 μM Na2SeO3), Na2SeO3 and SeMet inhibited cell proliferation associated with S-G2 blockage and DNA fragmentation leading to apoptosis caspase-3 dependant. SeMet only led to hydrogen peroxide production and to a decrease in mitochondrial transmembrane potential. Our study of the effects of selenium on HaCaT cells reaffirm the necessity to take into account the chemical form in experimental and intervention studies.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Selenium is an essential trace element for humans, included in selenoproteins as the 21st aminoacide Selenocystein (SeCys) [1]. Alternatively, SeMet can be incorporated non-specifically into proteins in place of methionine [2]. Thus, one of physiological functions of Se is thought to result from its existence in a number of selenoproteins in which Se is present as the amino-acid selenocysteine. Se has been found (or predicted to be found) in 25 mammalian selenoproteins (for review see [3, 4]). SeCys is incorporated into the amino-acid sequence of seleprotein during translation, being coded for by a UGA codon in the coding region of mRNA [5]. The best characterized selenoproteins are the glutathione peroxidases (GPXs). Glutathione peroxidases (cytosolic GPX1, extracellular GPX3, phospholipid GPX4) have antioxidant functions through metabolization of hydrogen peroxide and some organic hydroperoxides in phospholipids (for review see [4]). Selenoprotein W1 (SEPW1) is ubiquitously expressed in tissues and its expression is regulated by selenium levels [6]. Moreover, SEPW1 has antioxidant properties [6, 7] and may be implied in cell cycle regulation [8–10]. The control of cell cycle progression plays a key role in terminal differentiation, growth and development. The connections between Se and the checks points at the G1/S and the G2/M transitions of the cell cycle have been reported [1, 9, 11–13].
Selenium has been shown in several studies to prevent the occurrence of some cancers [14]. The mechanisms that drive the selenium-anticancer action are not fully understood and may be led via antioxidant protection, enhanced immunity, regulation of cell proliferation, cell cycle modulation, apoptosis and inhibition of tumor cell invasion [1, 15].
Chemical form of selenium and selenium status at baseline may explain the discrepant results. The Nutritional Prevention of Cancer trial (NPC) [16] showed that Se, in the form of selenized yeast, in supra nutritional doses administered to male humans, exhibited cancer chemoprevention effects against prostate cancer, whereas the SELECT trial [17], in which the Se was administered as SeMet, did not show the same beneficial effect. It has been suggested that two main factors may explain the difference. The first was the baseline Se levels of the studied population, the benefit being limited to people with the lowest baseline Se concentrations. The second was that Se-enriched yeast may contain active Se species whereas SeMet had limited therapeutic effect. This underlines the interest of understanding the biological activities and molecular targets of the Se chemical forms available in commercial Se supplements [18, 19].
Despite increasing incidence of skin malignancies, at least in part attributed to the deleterious effect of UVA-generated ROS, only few studies reported the association between Se and UVA related skin lesions.
Dreno et al. showed that Se did not prevent the occurrence of skin cancer linked to human papilloma virus in an organ transplant recipient population [20]. In mice, Pence et al. have reported a correlation between the selenium (as Na2SeO3) level in the diet and both the number of skin tumours and the activities of catalase, superoxide dismutase (SOD) and GPX1 [21]. Dietary SeMet protected against UV-light-induced skin damage in mice and reduced both inflammation and skin pigmentation [22].
In vitro, it has been shown that Se added into the cell culture medium protected skin cells from UVA- [23, 24] and UVB-induced [25] cytotoxicity in a dose and chemical form manner. The proposed mechanism was a modification of redox balance as well as selenoprotein synthesis and autophagy [24–27].
It was reported a generation of reactive oxygen species (ROS) by Na2SeO3 [26, 28] as well as by SeMet [29] in cancer cells which triggered apoptosis. Apoptosis can occur by one or two representative pathways: the death receptor-mediated (extrinsic) pathway and the mitochondrial (intrinsic) pathway. Interaction of caspases plays an important role in either pathway. Caspase-3 belongs to executioner caspases (for review, see [30]). Apoptosis induction usually accompanies a loss of the mitochondrial transmembrane potential (MTP).
The aim of our experiments was to better understand the mechanisms involved in long term protective and deleterious effects of two selenium species (SeMet and Na2SeO3) found in commercially available supplements using HaCaT cell culture model submitted to UVA.
Materials and Methods
Chemicals
Seleno-L-methionine (SeMet, C5H11NO2Se) and sodium selenite (Na2SeO3) were purchased from Sigma-Aldrich. Stock solutions of SeMet and Na2SeO3 were prepared in Milli-Q water, filter sterilized and stored at 4 °C.
Cell Culture
HaCaT cells were propagated in RPMI-1640 supplemented with 10 % FCS (containing less than 20 nmol/l of Se), L-glutamine 2 mmol/l, penicillin 100 UI/ml and streptomycin 100 μg/ml (Life technologies, Saint Aubin, France), at 37 °C in a humidified atmosphere with 5 % CO2. Briefly, near confluent cells were trypsinized and plated at density of 1,000 cells/cm2 in cultures dishes (BD Biosciences). Twenty four hours after plating, when cells were in exponentially growing cultures, the culture medium was replaced by fresh medium and the specific Se compound was added directly into the media giving specific final concentrations. Cells were next incubated for 144 h (6 days) to determine working doses. Then, using either non-toxic or toxic doses, cells were used to analyse several parameters described.
For MDA, SH groups, GPX and selenium absorption analysis, cells were washed three times in 0.2 M Tris, pH 7.3 (Sigma) and resuspended in 400 μl of Tris hypotonic (Tris 0.01 M), in which cells were submitted to 5 cycles of frost (liquid nitrogen)–defrost (37 °C) to obtain cell lysates. For RNA extraction, after the washing phases, cell dry pellets were frozen in liquid nitrogen and stored at −80 °C until analysis.
Se Determination
Se was determinated by ICP-MS (X serie II, Thermo Fisher Scientific, Waltham, MA) equipped with a Collision Cell interference elimination Technology (CCT) in cell lysates (see above) after dilution in nitric acid 1 % containing Gd as internal standard. The gas introduced in the CCT was a mixture of He and H2. The isotope ratio 78Se/71Gd and an external calibration curve (16, 80 and 160 nmol Se/l) allowed the determination of selenium concentration expressed as nanomole per gram of total cell proteins.
UVA Radiation
HaCaT cells were exposed to UVA irradiation, delivered from Tecimex apparatus (Dixwell, St Symphorien d’Ozon, France) with λmax at 372 nm and the relative spectral distribution of the lamp has been described in [31]. In order to establish which UVA dose significantly decrease the viability of HaCaT cells, dose kinetics were performed from 5 to 50 J/cm2. Dose to induce 30 % cell death was chosen: 23 J/cm2. For MDA and thiol group determinations, cells were harvested immediately after irradiation to avoid their repair. For GPX activity, cell cycle, apoptosis and MTT assays, cells were harvested 24 h after irradiation to allow the cell to trigger a response. Cells were centrifuged at 300×g, 3 min.
Cell Viability
Cell viability was determined colorimetrically using the 3-(4,5-dimethylthiazol-2yl)-2,5-diphenyl tetrazolium bromide (MTT; Sigma, Saint Quentin Fallavier, France) assay [32]. Cell viability was reported as the percentage absorbance relative to the control. IC50 (concentrations inducing 50 % cell death) values were determined by curve-fitting plots of cell viability versus Se compound concentration.
Mitotic Index, Morphological Appearance and Microphotography
Optical micrographs of the cells in culture were obtained using the Leica inverted microscope (Wetzlar, Germany; ×400) and cells were trypsined and washed twice in Hank’s Buffered Salt Solution (HBBS). Mitotic index (MI) was determined by using cells fixed on glass slides by cytospin apparatus (Shandon, Pittsburgh, PA) with further May–Grünwald Giemsa (MGG) staining. The MI was determined as the percentage of mitotic figures of 300 cells from each sample with conventional analysis using a Zeiss microscope (Oberkochen, Germany) as previously described [33]. Microphotographs were taken using a Canon Power Shot S50 digital camera (Canon, Courbevoie, France).
Cell Cycle, Apoptosis and Caspase-3 Activity Determinations
Cell DNA content was analysed with IP staining using the CycleTestTM PLUS/DNA reagent kit (Biosciences, San Jose, CA) after 6 days selenium supplementation, according to manufacturer recommendations. Data were collected on FACS Canto II flow cytometer (Becton Dickinson, San José, CA) using FACS DIVA software (Biosciences) and the phases of the cell cycle were determined. Apoptosis was evaluated as the percentage of cells in the sub-G0/G1 phase then confirmed using the Annexin V-FITC/PI method (VybrantTM Apoptosis Assay kit, Molecular Probes, Eugene, OR) using flow cytometry analysis. The role of caspase-3 in the apoptotic process was determined by the Caspase-3 Fluorometric Assay (R&D Systems, Minneapolis, MN) as described by the manufacturer.
Measurement of Transmembrane Mitochondrial Potential (MTP)
Na2SeO3 or SeMet HaCaT treated cells were stained with 40 nM of 3,3′-dihexyloxacarbocyanine iodide (DiOC6) (Molecular Probes, Eugene, OR) at 37 °C for 30 min. Cells were washed twice with PBS and analysed by flow cytometer [34]. The MTP was expressed as the percentage of cells showing a decrease in the fluorescence intensity as determined using FACS Diva software (Biosciences).
Measurement of Intracellular Hydrogen Peroxide
Intracellular hydrogen peroxide was detected by means of an oxidation-sensitive fluorescent dye 2′,7′-dichlorofluorescein diacetate (DCFDA; Molecular Probes, Eugene, OR). DCFDA was deacetylated by nonspecific esterase (NSE) then oxidized by a peroxide to a fluorescent compound (DCF). Briefly, trypsinized cells were incubated with DCFDA (at a final concentration of 5 μM) at 37 °C for 30 min then washed twice with PBS and analysed by flow cytometer. Hydrogen peroxide production was expressed as the percentage of cells showing an increase in the fluorescence intensity as determined using FACS Diva software (Biosciences).
GPX1 Activity
GPX1 activity was measured using the glutathione reductase (GSR)-NADPH method [35]. GPX1 activity was expressed in terms of nanomoles of NADPH oxidized per minute per milligram of protein.
SEPW1 RT-q-PCR
Total RNA extraction was performed with RNeasy Mini Kit (Qiagen, Courtaboeuf, France) following manufacturer recommendations. Total RNA was treated with RNase-free DNase I (Qiagen, Courtaboeuf, France). cDNA was reverse transcribed from 1 μg of total RNA with the SuperScriptIII First-Strand Synthesis (Life Technologies, Saint Aubin, France). As recommended, an RNase H treatment was added.
Real time RT-PCR was conducted using the QuantiTect SYBR Green RT-PCR kit (Qiagen) and a Stratagene (Mx3005P, La Jolla, CA). The primers (5′-3′) SEPW1 sense GCCGTCCGAGTCGTTTATTGT antisens GGCTACCATCACTTCAAAGAACC (Tm 60 °C, 400 nM) and HPRT1 sense CTCATGGACTGATTATGGACAGGAC antisense GCAGGTCAGCAAAGAACTTATAGCC (Tm 60 °C, 400 nM) were chosen to include intron spanning. Primers were synthesized by Life Technologies.
Gene expression was quantified using the comparative threshold cycle (Ct) method [36]. The amount of target gene, normalized to an endogenous reference gene (HPRT1), was expressed relative to the control cells (without Se supplementation).
Malondialdehyde Measurement
MDA, an end product of lipid peroxidation process [37], was determined using the separation of MDA- thiobarbituric acid (TBA) adducts on reversed-phase HPLC as previously described [38]. The results were expressed as micromole per gram of total cell proteins.
Quantitative Determination of Thiol Groups
Protein oxidation protection was evaluated by thiol groups (SH) determination [39, 40]. The results were expressed as micromole per gram of total cell proteins.
Quantitative Protein Determination
Protein levels in total cell lysates and in soluble fractions were determined using the BCATM Bincinchoninic acid kit (Interchim, Montluçon), according to manufacturer recommendations.
Statistical Analysis
Results are expressed as means ± SD for the number of experiments indicated. All statistical analysis of data was computed using StatView (SAS Institute, USA). The sources of variation for multiple comparisons were assessed by ANOVA. The differences were considered statistically significant at p < 0.05.
Results
Absorption of Selenium Depended on the Chemical Form
In order to evaluate the capacity of cells to absorb Se as a function of its chemical form, Se content was determined in cell lysates (Table 1). A negative relationship was observed between absorption and selenium concentration supplementations (for SeMet, p = 0.0017 and p = 0.0001 for Na2SeO3 in the lysates). In addition, Se from Na2SeO3 was poorly absorbed compared to SeMet.
Selenium Toxicity Differed as a Function of Dose and Chemical Form
SeMet was better tolerated than Na2SeO3 in HaCaT cells (Fig. 1a). Indeed, the IC50 of SeMet is about 24-fold higher than IC50 of Na2SeO3 (55.4 μM versus 2.3 μM). Two working zones were determined to better understand biological effects of Se: a non-toxic and a toxic zone. The working doses were 1 μM Na2SeO3 and 10 μM SeMet for the non-toxic dose and 5 μM Na2SeO3 and 100 μM SeMet which represented 80 % toxicity.
The toxicity of selenium compounds can be visualized by cell morphology changes, as seen by photographs of cytocentrifuged HaCaT after MGG staining (Fig. 1b). HaCaT cells at not toxic doses (c and e, respectively) were morphologically comparable to the control (a). On the contrary, at toxic doses (5 μM Na2SeO3 and 100 μM SeMet), HaCaT cells exhibited a cytoplasmic vacuolization and detachments from dishes (i and g). Nevertheless, SeMet morphological changes were related to autophagy (data not shown) whereas Na2SeO3 treatment induced apoptosis. MGG staining showed that few cells Na2SeO3- and SeMet-treated showed mitotic figures (MI = 0.2 in control vs 0.6 and 1.2 for 5 μM Na2SeO3 and 100 μM SeMet, respectively) (b, j and h).
DNA fragmentation was induced after 144 h treatment in HaCaT cells by SeMet at 100 μM (20 % in average) and Na2SeO3 at 5 μM (25 % in average; Fig. 1c).
Cell Death Process Characterization: Hydrogen Peroxide, MTP and Caspase-3 Analysis
In order to characterize Se toxicity causing, ROS production, MTP and cell death, flow cytometry analyses after propidium iodide, DCFDA, DiOC6 or Annexin V-FITC/PI staining were respectively performed. Moreover, to better describe apoptosis Se-induced, caspase-3 activity was determined after 144 h treatment.
After a 144-h treatment in HaCaT cells, DNA fragmentation was associated with hydrogen peroxide production (Fig. 2a) and a decrease in MTP (Fig. 2b) when using SeMet at 100 μM but not Na2SeO3 at 5 μM. Both forms induced apoptosis (Fig. 2c) and caspase-3 activity (Fig. 2d). With SeMet, necrosis was also involved although to a lesser extent.
SeMet Protected HaCaT Cells from UVA-Induced Toxicity
The UVA dose was chosen to induce 20.6±3.3 % cell toxicity 24 h after UVA exposure, i.e. 23 J/cm2 in HaCaT cells (Fig. 3). At non-toxic doses, only HaCaT supplementation with SeMet protected HaCaT from the UVA-radiation inducing cell death in a dose independent way (Fig. 4a). Na2SeO3 supplementation did not exhibit protection toward mortality-UVA induced (Fig. 4a).
SeMet and Na2SeO3-Induced GPX Activity
At non-toxic doses, GPX activity was induced by both SeMet and Na2SeO3 treatment. Using toxic doses, GPX activity was not detected (Fig. 4b) due to a cell death process.
SeMet and Na2SeO3-Induced SEPW1 Transcript Expression
At non-toxic doses, SEPW1 transcript expression was significantly induced by both components (Fig. 4c). At toxic dose, SEPW1 transcript was not detected.
SeMet and Na2SeO3 Did Not Modulate MDA Levels at Baseline Nor SH Group Levels
At baseline (without UVA), MDA levels were not changed by the supplementation with either non-toxic doses of SeMet (0.15 ± 0.01 μmol/mg proteins in control cells versus 0.14 ± 0.01 μmol/mg proteins in cells supplemented with 10 μM SeMet) or Na2SeO3 (0.15 ± 0.04 μmol/mg proteins in control cells versus 0.13 ± 0.04 μmol/mg proteins in cells supplemented with 1 μM Na2SeO3). When cells were UVA-irradiated, MDA significantly increased but neither the Na2SeO3 nor SeMet supplementation had any effect to protect cells from UVA-deleterious effect on lipid damages (irradiated untreated cells, 0.18 ± 0.04 μmol/mg proteins; irradiated cells treated by 1 μM Na2SeO3, 0.14 ± 0.02; irradiated cells treated by 10 μM SeMet, 0.13 ± 0.03 μmol/mg proteins).
SH-group concentrations did not vary after SeMet or Na2SeO3 supplementation at baseline (137.8 ± 20.0 μmol/mg proteins in controls cells versus 125.3 ± 16.5 μmol/mg proteins in cells treated by 10 μM SeMet and 135.7 ± 6.9 μmol/mg proteins in cells treated by 1 μM Na2SeO3). After UVA irradiation, the percentage of SH groups remaining was similar in supplemented HaCaT cells whatever Se chemical form (141.0 ± 22.8 μmol/mg proteins in cells irradiated and not treated).
Cell Cycle Modulation
Cell cycle analysis was performed following propidium iodide staining using flow cytometry (Table 2). As showed above, MGG staining illustrated that very few cells SeMet and Na2SeO3 treated showed mitotic figures suggesting that the blockage was in the G2 phase of the cell cycle (Fig. 1b (h, j), respectively).
HaCaT cells treated with 10 and 100 μM SeMet were arrested in the S/G2 phase of the cell cycle. At non-toxic dose (10 μM), this arrest was not associated neither with apoptosis nor necrosis (1.2 % ± 0.9 necrotic and 8.4 % ± 3.2 apoptotic cells not treated versus 0.6 %±0.3 necrotic and 5.2 % ± 1.8 apoptotic SeMet treated cells) whereas it was so at the toxic dose (100 μM SeMet) as shown in Fig. 2c.
Na2SeO3 at 5 μM arrested HaCaT cells in the S/G2 phase whereas no effect was observed at non-toxic dose (1 μM). The arrest observed at 5 μM Na2SeO3 was associated with apoptosis and necrosis as shown in Fig. 2c.
Discussion
The data presented herein support the hypothesis that Na2SeO3 (inorganic) and SeMet (organic) compounds have different metabolisms and distinct modes of actions in inducing apoptosis, modulating the cell cycle and triggering antioxidant responses.
In this study, HaCaT immortalized keratinocytes cells were chosen as they are a well-accepted paradigm for an early stage of skin cancer development [41]. This model is thus relevant to study antioxidant Se properties in parallel to its toxic activities. Previous studies have reported the antioxidant properties of both SeMet and Na2SeO3 as well as Na2SeO3 toxicity using different cell models but to our knowledge this is the first report dealing with SeMet toxicity. In addition, in contrast to many published studies, our aim was to mimic long term supplementation using a 6-day-supplementation period. Finally, HaCaT cells have never been evaluated.
It is noted that Se uptake from Na2SeO3 was very low in HaCaT cells which was comparable to that observed with PC-3 and Jurkat cells [42]. The low Se uptake could be due to an adaptative response of the cells to the higher toxicity of Na2SeO3 compared to that of SeMet. Indeed, several studies on selenium absorption across intestinal barrier models have shown a net absorptive flux across the Caco-2 cell monolayer. This suggested that a transporter-mediated transcellular pathway was involved for SeMet, while a paracellular pathway for Na2SeO3 was preferred, which is supported by the low intracellular concentration [13, 43, 44]. Moreover, the metabolism of Se also depends on which form it is ingested [45]. In humans, the organic food forms of Se are better absorbed than the inorganic forms [46, 47] even though they are transformed into the selenide state [1] prior to their incorporation into the proteins [5]. However, our results demonstrated that the small amount of Na2SeO3 entering into the cells was sufficient to induce important increases of GPX1 and SEPW1 and cell death by apoptosis, via caspase-3, depending on the concentration. Although Na2SeO3 is rarely present in foods [48], it is also reduced metabolically to selenide and converted enzymatically to SeCys. Accordingly, these inorganic Se species can act like SeCys to supply Se for SP synthesis. Apart from their different mechanisms of absorption, the metabolic fates of these forms of Se are quite similar, due to their conversion to selenide and SeCys prior to their incorporation into SP [1].
At sub-toxic doses, both Na2SeO3 and SeMet exhibit antioxidant properties, and both SeMet and Na2SeO3 optimized the SEPW1 transcript expression and GPX1 biosynthesis, but only SeMet protected HaCaT from UVA-dose-induced cytotoxicity. Rafferty et al. showed that SeMet conferred substantial protection from high UVB-dose-induced cytotoxicity in keratinocytes [25]. The same authors showed that the protective effect was more modest and required higher Se dosages when the supplementation occurred prior to, than after UV irradiation. Other authors reported that Na2SeO3 increased the survival of UVA-irradiated fibroblasts [23].
Interestingly, neither SeMet nor Na2SeO3 significantly affected the MDA concentration. Na2SeO3 at 0.58 μM has been shown to reduce the levels of thiobarbituric acid-reacting substances (TBARS), another lipid peroxidation marker, in fibroblasts [23]. Moreover, these data suggest that the UVA-protection can be due to the Se incorporation into SP causing an enhancement of the GPX1 activity and the levels of SEPW1 transcript expression rather than a direct antioxidant effect, which could explain why the levels of MDA were not decreased by both Se treatments chosen. It is worth to be noted that the concentration of the protein SH-groups remained unchanged by addition of non-toxic doses of both SeMet and Na2SeO3 or by UVA irradiation despite it has been demonstrated that selenite reacts immediately and directly with thiols, simultaneously generating superoxide [49, 50].
Although both compounds conferred antioxidant protection, the window range of protection was higher for SeMet.
Selenium is essential for the growth of cells in culture [51] but with a relatively narrow window of tolerance [12]. In the same time, Se inducing cell cycle arrest can be a mechanism arising before apoptosis caused by non-specific genotoxic effects manifested by single strand breaks and cytotoxicity [52–54], as shown in this study. At non-toxic dose, SeMet induced an arrest in S/G2 which was not observed for Na2SeO3, suggesting another cell cycle regulatory process. Previous studies have reported a significant effect of the chemical form on the metabolic pathways [52–55]. At toxic dose, Na2SeO3 and SeMet led to an arrest in the S-G2/M phases. This blockage was rather in the G2 phase, (as confirmed by the MGG staining) possibly in response to ROS-inducing DNA fragmentation and then apoptosis, as shown in previous studies [11, 53]. This arrest has been associated with increased expression of Growth Arrest DNA damage (GADD) -45 and −34 [11], a decrease in cyclins D1, E and A which bound cycline-dependant-kinases (cdk) [53]. Some studies showed that organic Se compounds (i.e. methylselenocysteine) and their metabolites (i.e. methylselenol) rather induced a G1 cell cycle arrest associated with a modulation of cell cycle actors [53, 56, 57], such as CDKN1C/p57KIP2 [58] suggesting that methylselenol have potent anti-cancer properties [57, 59, 60]. Despite degradation of SeMet to methylselenol by γ lyase action has been reported [61], we did not evidence any arrest in G1 under SeMet supplementation.
Another actor in cell cycle modulation by selenium may be SEPW1. We showed that SEPW1 transcript expression was increased in both Na2SeO3- and SeMet-treated cells (at non-toxic doses). In this work, we did not focus on a correlation between cell cycle arrest and SEPW1 expression but some studies showed that its depletion induced a G1 arrest in non-tumorigenic and cancer cells lines [8–10] that may be mediated by p53 and p21 [10].
It is well known that organoselenium compounds are less toxic than inorganic compounds. Indeed, in this study, Na2SeO3 caused apoptosis in HaCaT cells when present at a concentration approximately 24 times lower than SeMet. Our results suggest that the reported anti-tumor effects of Na2SeO3 [26, 28, 30, 62–64] and SeMet may be due to its toxicity. Moreover, we established that HaCaT cells were able to absorb more Se than normal human skin fibroblast (0.5 % for Na2SeO3 and 3.5 % for SeMet, unpublished data) showing that immortalized cells may be more sensitive to Se toxicity than normal cells.
We illustrated that Na2SeO3 induced the cell death process in parallel to DNA fragmentation, cell cycle arrest (in S/G2) and apoptosis (via caspase-3). Previous reports showed that the subsequent apoptosis to Na2SeO3-induced-DNA damage followed different mechanisms of action [52–54, 65, 66]. Among them, ROS mediated the activation of caspases [26, 67]. This may directly imply the reduced form of selenite, the selenide, which, in sufficient concentrations, with oxygen and thioredoxin reductase is able to form ROS. This reaction is considered to be a mechanism of Se toxicity in which Se is transformed from antioxidants to prooxidants [68]. Nevertheless, hydrogen peroxide generation and MTP decrease were not detected at 30 min and 1, 2, 4, 24, 48 and 144 h Na2SeO3 treatment (data not shown). This suggests that in HaCaT cells, hydrogen peroxide may not be the main ROS involved in Na2SeO3-induced apoptosis. Indeed, previous report have documented that Na2SeO3 generated hydrogen peroxide ROS [26, 28] (peak at 2 h treatment for 20 and 6 μM respectively) but also anion superoxide [62] (peak at 6 h for 7 μM treatment) in different cancer cells. Moreover, it is reported that selenium compounds induced mitochondrial permeability transition [55, 62].
Even though the exact mechanism of ROS generated by SeMet is unknown, we showed here that SeMet was able to generate hydrogen peroxide, DNA fragmentation and apoptosis via caspase-3, in the same proportion than Na2SeO3. It was found that mTOR activation signaling pathway and Akt played a pro-apoptotic role in SeMet induced-apoptosis [29]. Currently, we are investigating the mechanisms triggering apoptosis process, identifying apoptosis actors in HaCaT cells and the role of autophagy induced by Na2SeO3 and SeMet.
In summary, in a review of the mechanisms for selenium’s cancer preventive activity [59], it has been stated in 1999: “although it is convenient to describe the effects of selenium in terms of the element, it must always be kept in mind that the chemical form and dose are determinants of its biological activities as an essential nutrient, cancer preventive agent, or toxicant”. Our results corroborate this statement, emphasize the importance of considering not only the dose but also the chemical form in the interpretation of results and provided new insights into the mechanism of SeMet toxicity and the importance of ROS, MTP and caspase-3 in driving apoptotic death in HaCaT cells. However it is difficult to generalize our results to other cell types or to other operating conditions. SeMet should be tested in skin cancer cell lines to observe its potential anti-cancer effects.
Abbreviations
- DMSO:
-
dimethylsulfoxide
- CDK:
-
cycline dependant kinase
- DCFDA:
-
2′,7′-dichlorofluorescein diacetate
- DiOC6:
-
3,3′-dihexyloxacarbocyanine iodide
- FCS:
-
foetal calf serum
- GADD:
-
growth arrest and DNA damage
- GPX1:
-
glutathione peroxidase 1
- GSR:
-
glutathione reductase
- H2Se:
-
selenide
- HBSS:
-
Hank’s buffered salt solution
- HPLC:
-
high performance liquid chromatography
- HPRT1:
-
hypoxanthine phosphoribosyltransferase 1
- ICP-MS:
-
inductively coupled plasma mass-spectrometry
- mTOR:
-
mammalian target of rapamycin
- MDA:
-
malondialdehyde
- MGG:
-
May–Grünwald Giemsa
- MI:
-
mitotic index
- MTP:
-
mitochondrial transmembrane potential
- MTT:
-
3-(4,5-dimethylthiazol- 2yl)-2,5-diphenyl tetrazolium bromide
- NHSF:
-
normal human skin fibroblast
- ROS:
-
reactive oxygen species
- SB:
-
strand break
- SeCys:
-
selenocysteine
- SeMet:
-
selenomethionine
- Na2SeO3 :
-
sodium selenite
- SEPW1:
-
selenoprotein W1
- SH:
-
thiol groups
- SOD:
-
superoxide dismutase
- SP:
-
selenoprotein
- UVA:
-
ultraviolet-A
References
Zeng H, Combs GF Jr (2008) Selenium as an anticancer nutrient: roles in cell proliferation and tumor cell invasion. J Nutr Biochem 19(1):1–7
Allan CB, Lacourciere GM, Stadtman TC (1999) Responsiveness of selenoproteins to dietary selenium. Annu Rev Nutr 19:1–16
Hesketh J (2008) Nutrigenomics and selenium: gene expression patterns, physiological targets, and genetics. Annu Rev Nutr 28:157–177
Papp LV, Lu J, Holmgren A, Khanna KK (2007) From selenium to selenoproteins: synthesis, identity, and their role in human health. Antioxid Redox Signal 9(7):775–806
Hatfield DL, Gladyshev VN (2002) How selenium has altered our understanding of the genetic code. Mol Cell Biol 22(11):3565–3576
Jeong D, Kim TS, Chung YW, Lee BJ, Kim IY (2002) Selenoprotein W is a glutathione-dependent antioxidant in vivo. FEBS Lett 517(1–3):225–228
Beilstein MA, Vendeland SC, Barofsky E, Jensen ON, Whanger PD (1996) Selenoprotein W of rat muscle binds glutathione and an unknown small molecular weight moiety. J Inorg Biochem 61(2):117–124
Hawkes WC, Alkan Z (2011) Delayed cell cycle progression from SEPW1 depletion is p53- and p21-dependent in MCF-7 breast cancer cells. Biochem Biophys Res Commun 413(1):36–40
Hawkes WC, Printsev I, Alkan Z (2009) Selenoprotein W depletion induces a p53- and p21-dependent delay in cell cycle progression in RWPE-1 prostate epithelial cells. J Cell Biochem
Hawkes WC, Printsev I, Alkan Z (2012) Selenoprotein W depletion induces a p53- and p21-dependent delay in cell cycle progression in RWPE-1 prostate epithelial cells. J Cell Biochem 113(1):61–69
Kaeck M, Lu J, Strange R, Ip C, Ganther HE, Thompson HJ (1997) Differential induction of growth arrest inducible genes by selenium compounds. Biochem Pharmacol 53(7):921–926
Zeng H (2002) Selenite and selenomethionine promote HL-60 cell cycle progression. J Nutr 132(4):674–679
Zeng H, Botnen JH, Johnson LK (2008) A selenium-deficient Caco-2 cell model for assessing differential incorporation of chemical or food selenium into glutathione peroxidase. Biol Trace Elem Res 123(1–3):98–108
Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, Parsons JK, Bearden JD 3rd, Crawford ED, Goodman GE, Claudio J, Winquist E, Cook ED, Karp DD, Walther P, Lieber MM, Kristal AR, Darke AK, Arnold KB, Ganz PA, Santella RM, Albanes D, Taylor PR, Probstfield JL, Jagpal TJ, Crowley JJ, Meyskens FL Jr, Baker LH, Coltman CA Jr (2009) Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Jama 301(1):39–51
Jackson MI, Combs GF Jr (2008) Selenium and anticarcinogenesis: underlying mechanisms. Curr Opin Clin Nutr Metab Care 11(6):718–726
Clark LC, Combs GF Jr, Turnbull BW, Slate EH, Chalker DK, Chow J, Davis LS, Glover RA, Graham GF, Gross EG, Krongrad A, Lesher JL Jr, Park HK, Sanders BB Jr, Smith CL, Taylor JR (1996) Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. Jama 276(24):1957–1963
Lippman SM, Goodman PJ, Klein EA, Parnes HL, Thompson IM Jr, Kristal AR, Santella RM, Probstfield JL, Moinpour CM, Albanes D, Taylor PR, Minasian LM, Hoque A, Thomas SM, Crowley JJ, Gaziano JM, Stanford JL, Cook ED, Fleshner NE, Lieber MM, Walther PJ, Khuri FR, Karp DD, Schwartz GG, Ford LG, Coltman CA Jr (2005) Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT). J Natl Cancer Inst 97(2):94–102
Rayman MP, Combs GF, Jr., Waters DJ (2009) Selenium and vitamin E supplementation for cancer prevention. Jama 301 (18):1876; author reply 1877
Waters DJ, Shen S, Kengeri SS, Chiang EC, Combs GF Jr, Morris JS, Bostwick DG (2012) Prostatic response to supranutritional selenium supplementation: comparison of the target tissue potency of selenomethionine vs. selenium-yeast on markers of prostatic homeostasis. Nutrients 4(11):1650–1663
Dreno B, Euvrard S, Frances C, Moyse D, Nandeuil A (2007) Effect of selenium intake on the prevention of cutaneous epithelial lesions in organ transplant recipients. Eur J Dermatol 17(2):140–145
Pence BC, Delver E, Dunn DM (1994) Effects of dietary selenium on UVB-induced skin carcinogenesis and epidermal antioxidant status. J Invest Dermatol 102(5):759–761
Burke KE, Combs GF Jr, Gross EG, Bhuyan KC, Abu-Libdeh H (1992) The effects of topical and oral L-selenomethionine on pigmentation and skin cancer induced by ultraviolet irradiation. Nutr Cancer 17(2):123–137
Leccia MT, Richard MJ, Beani JC, Faure H, Monjo AM, Cadet J, Amblard P, Favier A (1993) Protective effect of selenium and zinc on UV-A damage in human skin fibroblasts. Photochem Photobiol 58(4):548–553
Meewes C, Brenneisen P, Wenk J, Kuhr L, Ma W, Alikoski J, Poswig A, Krieg T, Scharffetter-Kochanek K (2001) Adaptive antioxidant response protects dermal fibroblasts from UVA-induced phototoxicity. Free Radic Biol Med 30(3):238–247
Rafferty TS, McKenzie RC, Hunter JA, Howie AF, Arthur JR, Nicol F, Beckett GJ (1998) Differential expression of selenoproteins by human skin cells and protection by selenium from UVB-radiation-induced cell death. Biochem J 332(Pt 1):231–236
Chen XJ, Duan FD, Zhang HH, Xiong Y, Wang J (2012) Sodium selenite-induced apoptosis mediated by ROS attack in human osteosarcoma U2OS cells. Biol Trace Elem Res 145(1):1–9
Sengupta A, Lichti UF, Carlson BA, Ryscavage AO, Gladyshev VN, Yuspa SH, Hatfield DL (2008) Selenoproteins are essential for proper keratinocyte function and skin development. PLoS One 5(8):e12249
Park SH, Kim JH, Chi GY, Kim GY, Chang YC, Moon SK, Nam SW, Kim WJ, Yoo YH, Choi YH (2012) Induction of apoptosis and autophagy by sodium selenite in A549 human lung carcinoma cells through generation of reactive oxygen species. Toxicol Lett 212(3):252–261
Suzuki M, Endo M, Shinohara F, Echigo S, Rikiishi H (2011) Rapamycin suppresses ROS-dependent apoptosis caused by selenomethionine in A549 lung carcinoma cells. Cancer Chemother Pharmacol 67(5):1129–1136
Sanmartin C, Plano D, Sharma AK, Palop JA (2012) Selenium compounds, apoptosis and other types of cell death: an overview for cancer therapy. Int J Mol Sci 13(8):9649–9672
Emonet-Piccardi N, Richard MJ, Ravanat JL, Signorini N, Cadet J, Beani JC (1998) Protective effects of antioxidants against UVA-induced DNA damage in human skin fibroblasts in culture. Free Radic Res 29(4):307–313
Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65(1–2):55–63
Champelovier P, Mininno M, Duchamp E, Nicolle E, Curri V, Boumendjel A, Boutonnat J (2011) Cytotoxicity of chalcone derivatives towards glioblastoma. Anticancer Res 31(10):3213–3218
Ozgen U, Savasan S, Buck S, Ravindranath Y (2000) Comparison of DiOC(6)(3) uptake and annexin V labeling for quantification of apoptosis in leukemia cells and non-malignant T lymphocytes from children. Cytometry 42(1):74–78
Flohe L, Gunzler WA (1984) Assays of glutathione peroxidase. Methods Enzymol 105:114–121
Giulietti A, Overbergh L, Valckx D, Decallonne B, Bouillon R, Mathieu C (2001) An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. Methods 25(4):386–401
Mukai FH, Goldstein BD (1976) Mutagenicity of malonaldehyde, a decomposition product of peroxidized polyunsaturated fatty acids. Science 191(4229):868–869
Richard MJ, Guiraud P, Meo J, Favier A (1992) High-performance liquid chromatographic separation of malondialdehyde-thiobarbituric acid adduct in biological materials (plasma and human cells) using a commercially available reagent. J Chromatogr 577(1):9–18
Bulaj G, Kortemme T, Goldenberg DP (1998) Ionization-reactivity relationships for cysteine thiols in polypeptides. Biochemistry 37(25):8965–8972
Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82(1):70–77
Boukamp P (2005) UV-induced skin cancer: similarities–variations. J Dtsch Dermatol Ges 3(7):493–503
Lunoe K, Gabel-Jensen C, Sturup S, Andresen L, Skov S, Gammelgaard B (2011) Investigation of the selenium metabolism in cancer cell lines. Metallomics 3(2):162–168
Gammelgaard B, Rasmussen LH, Gabel-Jensen C, Steffansen B (2012) Estimating Intestinal Absorption of Inorganic and Organic Selenium Compounds by in Vitro Flux and Biotransformation Studies in Caco-2 Cells and ICP-MS Detection. Biol Trace Elem Res 145(2):248–256
Leblondel G, Mauras Y, Cailleux A, Allain P (2001) Transport measurements across Caco-2 monolayers of different organic and inorganic selenium: influence of sulfur compounds. Biol Trace Elem Res 83(3):191–206
Finley JW (2005) Selenium accumulation in plant foods. Nutr Rev 63(6 Pt 1):196–202
Thomson CD, Robinson MF, Butler JA, Whanger PD (1993) Long-term supplementation with selenate and selenomethionine: selenium and glutathione peroxidase (EC 1.11.1.9) in blood components of New Zealand women. Br J Nutr 69(2):577–588
Wastney ME, Combs GF Jr, Canfield WK, Taylor PR, Patterson KY, Hill AD, Moler JE, Patterson BH (2011) A human model of selenium that integrates metabolism from selenite and selenomethionine. J Nutr 141(4):708–717
Whanger PD (2002) Selenocompounds in plants and animals and their biological significance. J Am Coll Nutr 21(3):223–232
Caffrey PB, Frenkel GD (1997) Sensitivity of melphalan-resistant tumors to selenite in vivo. Cancer Lett 121(2):177–180
Zuo L, Li J, Yang Y, Wang X, Shen T, Xu CM, Zhang ZN (2004) Sodium selenite induces apoptosis in acute promyelocytic leukemia-derived NB4 cells by a caspase-3-dependent mechanism and a redox pathway different from that of arsenic trioxide. Ann Hematol 83(12):751–758
McKeehan WL, Hamilton WG, Ham RG (1976) Selenium is an essential trace nutrient for growth of WI-38 diploid human fibroblasts. Proc Natl Acad Sci U S A 73(6):2023–2027
Lu J, Jiang C, Kaeck M, Ganther H, Ip C, Thompson H (1995) Cellular and metabolic effects of triphenylselenonium chloride in a mammary cell culture model. Carcinogenesis 16(3):513–517
Sinha R, Said TK, Medina D (1996) Organic and inorganic selenium compounds inhibit mouse mammary cell growth in vitro by different cellular pathways. Cancer Lett 107(2):277–284
Thompson HJ, Wilson A, Lu J, Singh M, Jiang C, Upadhyaya P, el-Bayoumy K, Ip C (1994) Comparison of the effects of an organic and an inorganic form of selenium on a mammary carcinoma cell line. Carcinogenesis 15(2):183–186
Kim TS, Yun BY, Kim IY (2003) Induction of the mitochondrial permeability transition by selenium compounds mediated by oxidation of the protein thiol groups and generation of the superoxide. Biochem Pharmacol 66(12):2301–2311
Zeng H, Briske-Anderson M, Idso JP, Hunt CD (2006) The selenium metabolite methylselenol inhibits the migration and invasion potential of HT1080 tumor cells. J Nutr 136(6):1528–1532
Zeng H, Wu M, Botnen JH (2009) Methylselenol, a selenium metabolite, induces cell cycle arrest in G1 phase and apoptosis via the extracellular-regulated kinase 1/2 pathway and other cancer signaling genes. J Nutr 139(9):1613–1618
Jin RJ, Lho Y, Wang Y, Ao M, Revelo MP, Hayward SW, Wills ML, Logan SK, Zhang P, Matusik RJ (2008) Down-regulation of p57Kip2 induces prostate cancer in the mouse. Cancer Res 68(10):3601–3608
Ganther HE (1999) Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase. Carcinogenesis 20(9):1657–1666
Ip C (1998) Lessons from basic research in selenium and cancer prevention. J Nutr 128(11):1845–1854
Esaki N, Tanaka H, Uemura S, Suzuki T, Soda K (1979) Catalytic action of L-methionine gamma-lyase on selenomethionine and selenols. Biochemistry 18(3):407–410
Kim EH, Sohn S, Kwon HJ, Kim SU, Kim MJ, Lee SJ, Choi KS (2007) Sodium selenite induces superoxide-mediated mitochondrial damage and subsequent autophagic cell death in malignant glioma cells. Cancer Res 67(13):6314–6324
Yoon SO, Kim MM, Chung AS (2001) Inhibitory effect of selenite on invasion of HT1080 tumor cells. J Biol Chem 276(23):20085–20092
Yoon SO, Kim MM, Park SJ, Kim D, Chung J, Chung AS (2002) Selenite suppresses hydrogen peroxide-induced cell apoptosis through inhibition of ASK1/JNK and activation of PI3-K/Akt pathways. FASEB J 16(1):111–113
Snyder RD (1987) Effects of sodium selenite on DNA and carcinogen-induced DNA repair in human diploid fibroblasts. Cancer Lett 34(1):73–81
Kralova V, Benesova S, Cervinka M, Rudolf E (2012) Selenite-induced apoptosis and autophagy in colon cancer cells. Toxicol In Vitro 26(2):258–268
Yang Y, Huang F, Ren Y, Xing L, Wu Y, Li Z, Pan H, Xu C (2009) The anticancer effects of sodium selenite and selenomethionine on human colorectal carcinoma cell lines in nude mice. Oncol Res 18(1):1–8
Bjornstedt M, Kumar S, Bjorkhem L, Spyrou G, Holmgren A (1997) Selenium and the thioredoxin and glutaredoxin systems. Biomed Environ Sci 10(2–3):271–279
Acknowledgments
We would like to thank all the technicians for their technical assistance: Aurélie Dariz and Michelle Tripier-Champ for cell cultures, toxicity assays and RT-q-PCR, Sandra Grange and Angèle Kraviec for GPX1 activities and SH-groups determination, Laurence Puillet for MDA measurements, Marie-Christine Bouillet and Dominique André for selenium measurements.
Declaration of Interest
The authors declare that there are no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hazane-Puch, F., Champelovier, P., Arnaud, J. et al. Long-Term Selenium Supplementation in HaCaT Cells: Importance of Chemical Form for Antagonist (Protective Versus Toxic) Activities. Biol Trace Elem Res 154, 288–298 (2013). https://doi.org/10.1007/s12011-013-9709-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12011-013-9709-5